IUCD Method Briefs

Selected IUCD Resources

See Also:

Selected IUCD Resources (pdf)

Materials from Kenya

Kokonya D, Sinei S, Sekadde-Kigondu C, et al. Experience with IUCD insertion outside of menses in Kenya. E Afr Med 2000;77(7):369-73.

Mati JK, Hunter DJ, Maggwa BN, et al. Contraceptive use and the risk of HIV infection in Nairobi, Kenya. Int J Gynaecol Obstet 1995;48(1):61-67.

Morrison CS, Sekadde-Kigondu C, Miller WC, et al. Use of sexually transmitted disease risk assessment algorithms for selection of intrauterine device candidates. Contraception 1999;59(2):97-106.

Morrison CS, Sekadde-Kigondu C, Sinei SK, et al. Is the intrauterine device appropriate contraception for HIV-1-infected women? Br J Obstet Gynaecol 2001;108(8):784-90.

Morrison C, Waszak C, Katz K, et al. Clinical outcomes of two early postpartum IUD insertion programs in Africa. Contraception 1996;53(1):17-21.

National Council for Population and Development, Central Bureau of Statistics, and Macro International Inc. Kenya Demographic and Health Survey 1993 and Kenya Demographic and Health Survey 1998. Calverton, MD: National Council for Population and Development, Central Bureau of Statistics, and Macro International Inc., 1994 and 1999.

Richardson BA, Morrison CS, Sekadde-Kigondu C, et al. Effect of intrauterine device use on cervical shedding of HIV-1 DNA. AIDS 1999;13(15):2091-97.

Sekadde-Kigondu C, Mwathe EG, Ruminjo JK, et al. Acceptability and discontinuation of Depo-Provera, IUCD and combined pills in Kenya. E Afr Med J 1996;73(12):786-94.

Sinei S, Morrison C, Sekadde-Kigondu C, et al. Complications of use of intrauterine devices among HIV-1-infected women. Lancet 1998;351(9111):1238-41.

Sinei SK, M'riara G, Schulz KF, et al. The prevalence of Neisseria gonorrhoea and Chlamydia trachomatis in intra-uterine contraceptive acceptors in Kenya. J Obstet Gynaecol East Cent Afr 1988;7(2):71-73.

Stanback J, Omondi-Odhiambo, Omuodo D. Why Has IUD Use Slowed in Kenya? Part A. Qualitative Assessment of IUD Service Delivery in Kenya. Final Report. Research Triangle Park, NC: Family Health International, 1995.

Additional materials

Family Health International. Intrauterine devices. Network 2000;20(1):1-20.

Farley TM, Rosenberg MJ, Rowe PJ, et al. Intrauterine devices and pelvic inflammatory disease: an international perspective. Lancet 1992;339(8796):785-88.

Franks AL, Beral V, Cates W Jr, et al. Contraception and ectopic pregnancy risk. Am J Obstet Gynecol 1990;163(4 Pt 1):1120-23.

Hubacher D, Grimes DA. Noncontraceptive health benefits of intrauterine devices: a systematic review. Obstet Gynecol Surv 2002;57(2):120-28.

Hubacher D, Lara-Ricalde R, Taylor DJ, et al. Use of copper intrauterine devices and the risk of tubal infertility among nulligravid women. N Engl J Med 2001;345(8):561-67.

International Planned Parenthood Federation. Charter on Sexual and Reproductive Rights. London, England: International Planned Parenthood Federation, 1996.

Janowitz B, Meashan D, West C. Issues in the Financing of Family Planning Services in Sub-Saharan Africa. Research Triangle Park, NC: Family Health International, 1999.

Johns Hopkins School of Public Health Population Information Program. IUDs – an update. Popul Rep B 1995;6:1-36.

Kapiga SH, Lyamuya EF, Lwihula GK, et al. The incidence of HIV infection among women using family planning methods in Dar es Salaam, Tanzania. AIDS 1998;12(1):75-84.

Shelton JD. Risk of clinical pelvic inflammatory disease attributable to an intrauterine device. Lancet 2001;357(9254):443.

Stewart GK. Intrauterine devices. In Hatcher RA, Trussell J, Stewart F, et al., eds. Contraceptive Technology Seventeenth Revised Edition. New York, NY: Ardent Media, Inc., 1998.

United Nations. Report of the Fourth World Conference on Women. Beijing Declaration and Platform for Action. United Nations, 1995.

United Nations Population Fund. Programme of Action of the International Conference on Population and Development. United Nations Population Fund, 1994.

World Health Organization. Improving Access to Quality Care in Family Planning. Medical Eligibility Criteria for Contraceptive Use. Third Edition. Geneva, Switzerland: World Health Organization, 2004.

World Health Organization. Selected Practice Recommendations for Contraceptive Use. Geneva, Switzerland: World Health Organization, 2002.

return to top of page

return to table of contents